ishigaki glutathione supplier Product Review: Premium Plus Ishigaki Advance vs Ishigaki Premium

For patients classified as intermediate-/low-risk treated with a protocol using ATRA plus chemotherapy, the role of maintenance is still controversial due to low relapse risk, especially for those achieving complete molecular remission at the end of consolidation

A., Kyle, R

Differences in the mechanisms of proapoptotic BH3 proteins binding to BCL-XL and BCL-2 quantified in live MCF-7 cells

Glycinebetaine-induced modulation of antioxidant enzymes activities and ion accumulation in two wheat cultivars differing in salt tolerance

Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies

P., Muddiman D